Evaluation of bias of the influx constant estimated by Patlak analysis for [18F]FDOPA PET: Influence of metabolites for [18F] FDOPA

Transactions of Japanese Society for Medical and Biological Engineering

Volumn 48, Issue 1, 2010, Pages 66-74

  Matsubara, Keisuke ^a   Watabe, Hiroshi ^b   Hayashi, Takuya ^b,c   Minato, Kotaro ^a   Iida, Hidehiro ^b  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c RIKEN   (Japan)

Author keywords

18F fDOPA; Kinetic analysis; Patlak analysis; PET

Indexed keywords

[18F]FDOPA; K-VALUES; KINETIC ANALYSIS; NEUROLOGICAL DISORDERS; PARKINSON'S DISEASE; PATLAK ANALYSIS; PET; PET DATA; PET SCAN; RADIOLIGANDS; STRIATUM; TIME-ACTIVITY CURVES;

BIOMOLECULES; BRAIN; DIAGNOSIS; METABOLITES; POSITRON EMISSION TOMOGRAPHY;

METABOLISM;

6 FLUORODOPA;

ARTICLE; CLEARANCE; CONSTANTS AND COEFFICIENTS; CORPUS STRIATUM; DOPAMINE METABOLISM; HUMAN; KINETICS; METABOLITE; MODEL; MONKEY; POSITRON EMISSION TOMOGRAPHY;

EID: 78649855751     PISSN: 18814379     EISSN: 1347443X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. 18F]6-fluoro-L-3, 4-dihydroxyphenylalanine in the hooded rat. J Neurochem. 48:601-608, 1987.
2. 18F] fluoro-L-3, 4-dihydroxyphenylalanine in the primate. J Neurochem. 48:1077-1082, 1987.
3. Cooper JR, Broom FE, Roth RH : The Biochemical Basis of Neuropharmacology. Oxford University Press, 2003, pp 197-234.
4. Martin WR, Palmer MR, Patlak CS, Calne DB : Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol. 26:535-42,1989.
5. Patlak CS, Blasberg RG: Graphical evaluation of blood-tobrain transfer constants from multiple-time uptake data, generalizations. J Cereb Blood Flow Metab. 5:584-590, 1985.
6. 18Fdopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatr. 76:1204-1210, 2005.
7. Dreher JC, Meyer-Lindenberg A, Kohn P, Berman KF: Age-related changes in midbrain dopaminergic regulation of the human reward system. Proc Natl Acad Sci USA. 105:15106-15111, 2008.
8. 18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat. J Neurochem. 63:1675-1682,1994.
9. 18F] 6-fluoro-L-dopa metabolites in nonhuman primate: implications for the kinetics of therapeutic L-dopa. Front Biosci. 9:505-512, 2004.
10. Yu DC, Huang SC, Barrio JR, Phelps ME : The assessment of the non-equilibrium effect in the'Patlak analysis'of Fdopa PET studies. Phys Med Biol. 40:1243-1254,1995.
11. Holden JE, Doudet D, Endres CJ, Chan GLY, Morrison KS, Vingerhoets FJG, Snow BJ, Pate BD, Sossi V, Buckley KR, Ruth TJ : analysis of 6-fluoro-L-dopa trapping: Effect of inhibition of catechol-O-methyltransferase. J Nucl Med. 38:1568-1574,1997.
12. Sossi V, Doudet DJ, Holden JE: A reversible tracer analysis approach to the study of effective dopamine turnover. J Cereb Blood Flow Metab. 21:469-476, 2001.
13. Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P : storage capacity in caudate and putamen of patients with early Parkinson' s disease: correlation with asymmetry of motor symptoms. J Cereb Blood Flow Metab. 26:358-370, 2006.
14. Kudomi N, Choi E, yamamoto S, Watabe H, Kim K, Shidahara M, Ogawa M, Teramoto N, Sakamoto E, Iida H: Development of a GSO detector assembly for a continuous blood sampling system. IEEE Trans Nucl Sci. 50:70-73, 2003.
15. Cumming P, Yokoi F, Chen A, Deep P, Dagher A, Reutens D, Kapczinski F, Wong D, Gjedde A : Pharmacokinetics of radiotracers in human plasma during positron emission tomography. Synapse. 34:124-34,1999.
16. Wahl L, Nahmias C: Modeling of fluorine-18-6-fluoro-Ldopa in humans. J Nucl Med. 37:432-437,1996.
17. 18F]fluorodopamine storage capacity. J Cereb Blood Flow Metab. 25:807-819, 2005.
18. Cumming P, Gjedde A:Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse. 29:37-61, 1998.
19. 18F] fluoro-L-dopa in the rhesus monkey brain. J Cereb Blood Flow Metab. 11:726-34,1991.
20. Hornykiewicz O, Kish SJ : Biochemical pathophysiology of Parkinson's disease. Adv Neurol. 45:19-34,1987.
21. Pifl C, Hornykiewicz O : turnover is upregulated in the caudate/putamen of asymptomatic MPTPtreated rhesus monkeys. Neurochem Int. 49:519-24,2006.
22. 18F-fluorodopa data. J Cereb Blood Flow Metab. 22:232-9, 2002.
23. 18F] fluorodopamine in vivo. J Neurosci Methods. 76:157-165,1997.
24. Ishikawa T, Dhawan V, Chaly T, Margouleff C, Robeson W, Dahl JR, Mandel F, Spetsieris P, Eidelberg D: Clinical significance of striatal dopa decarboxylase activity in Parkinson's disease. J Nucl Med. 37:216-222,1996.
25. Westerink BHC, Spaan SJ : Estimation of the turnover of 3methoxytyramine in the rat striatum by HPLC with electrochemical detection: Implications for the sequence in the cerebral metabolism of dopamine. J Neurochem. 38: 342-347,1982.
26. 18F] fluoro-dopa metabolism in monkeys and humans: Biochemical parameters for the formulation of tracer kinetic models with positron emission tomography. J Cereb Blood Flow Metab. 11: 890-897,1991.
27. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R : Inhibition of monoamine oxidase b in the brains of smokers. Nature. 379:733-736,1996.
28. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I:Neuropharmacological actions of cigarette smoke: brain monoamine oxidase b (mao b) inhibition. J Addict Dis. 17:23-34,1998.